Ameluz European Union - English - EMA (European Medicines Agency)

ameluz

biofrontera bioscience gmbh - 5-aminolevulinic acid hydrochloride - keratosis, actinic; carcinoma, basal cell - antineoplastic agents - treatment of actinic keratosis of mild to moderate severity on the face and scalp (olsen grade 1 to 2; see section 5.1) and of field cancerization in adults.treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.

TRUDHESA- dihydroergotamine mesylate spray, metered United States - English - NLM (National Library of Medicine)

trudhesa- dihydroergotamine mesylate spray, metered

impel pharmaceuticals inc. - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - trudhesa is indicated for the acute treatment of migraine with or without aura in adults. limitations of use trudhesa is not indicated for the preventive treatment of migraine. trudhesa is not indicated for the management of hemiplegic or basilar migraine. trudhesa is contraindicated in patients: - with concomitant use of strong cyp3a4 inhibitors, such as protease inhibitors (e.g., ritonavir, nelfinavir, or indinavir), macrolide antibiotics (e.g., erythromycin or clarithromycin), and antifungals (ketoconazole or itraconazole) [see warnings and precautions (5.1) and drug interactions (7.1)] - with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or patients who have clinical symptoms or findings consistent with coronary artery vasospasm, including prinzmetal's variant angina [see warnings and precautions (5.4)] - with uncontrolled hypertension [see warnings and precautions (5.5)] - with peripheral arterial disease - with sepsis - following vascular surge

Dimethyl fumarate Polpharma European Union - English - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dutasteride/Tamsulosin Polpharma 0.5mg/0.4mg Hard Capsules Malta - English - Medicines Authority

dutasteride/tamsulosin polpharma 0.5mg/0.4mg hard capsules

pharmaceutical works polpharma sa 19 pelplinska steet, 83-200 starogard gdanski, poland - dutasteride, tamsulosin hydrochloride - hard capsule - tamsulosin hydrochloride 0.4 mg dutasteride 0.5 mg - urologicals

Beromun European Union - English - EMA (European Medicines Agency)

beromun

belpharma s.a. - tasonermin - sarcoma - immunostimulants, - beromun is indicated in adults as an adjunct to surgery for subsequent removal of the tumour so as to prevent or delay amputation, or in the palliative situation, for irresectable soft-tissue sarcoma of the limbs, used in combination with melphalan via mild hyperthermic isolated-limb perfusion (ilp).